|
|
The Executive Summary: World Market for Prescription Orthopedic DrugsPublished by: Kalorama Information Executive Summaries Published: Oct. 1, 2006 - 7 Pages Table of ContentsPlease Note: Due to the brevity and/or nature of the content posted, there is no table of contents available for this report. AbstractKalorama Information's Executive Summaries provide a comprehensive overview of the contents contained in our full-length market intelligence reports.Containing a snapshot of the overall market analysis, each Executive Summary provides a description of the scope and methodology used in the report; a summary of results including market size and market growth; a sampling of charts and graphs when available; and a brief look at the trends shaping the market. The report from which this Executive Summary is compiled is World Market for Prescription Orthopedic Drugs, and the full study abstract is as follows: The orthopedic drug market is a highly competitive market and, in some areas, the competitive environment is being shaped by increasing levels of generic competition. Several large pharmaceutical companies compete in the orthopedic drug market, including Abbott, Eli Lilly, GlaxoSmithKline, Merck, Novartis, and Pfizer among others, and several other suppliers, such as Serono, NovoNordisk, Amgen, and Genentech are developing or offering products in more niche market areas. For the purposes of this study, the world market for orthopedic drugs has been segmented in a few general treatment segments:
|
|
|||
|
About MarketResearch.com
|
||||